Source comparison
Melanotan-2 Side Effects Long Term Research: Comparison of Documented Effects
Sustained Hypertension MC4R-mediated sympathetic tone increase Persists 12+ weeks post-cessation in 43% of users (Cardiovascular Toxicology 2023) Vascular remodeling reversal: 16–24 weeks Increases cardiovascular event risk; requires monitoring in users with p
This comparison does not assign a generated winner or score.
- Sustained Hypertension
- MC4R-mediated sympathetic tone increase
- Persists 12+ weeks post-cessation in 43% of users (Cardiovascular Toxicology 2023)
- Vascular remodeling reversal: 16–24 weeks
- Increases cardiovascular event risk; requires monitoring in users with pre-existing hypertension
- Receptor Downregulation
- MC1R density reduction from chronic overstimulation
- Detectable after 8 weeks continuous use
- Partial recovery 16–24 weeks; full recovery unclear
- Reduces tanning efficacy over time; causes patchy pigmentation
- Atypical Nevi Increase
- MC1R-driven melanocyte proliferation
- Observed in users with 24+ weeks cumulative exposure
- Nevi formation is permanent; does not reverse with cessation
- Independent melanoma risk factor. Dermatology follow-up recommended
- Immune Suppression
- MC3R/MC5R-mediated cytokine profile shift
- Case reports document effects during active use only
- Immune function normalises 8–12 weeks post-cessation
- May increase infection risk or latent viral reactivation during use
- Uneven Pigmentation
- Heterogeneous MC1R downregulation across body regions
- Persists 6–12 months in case reports
- Gradual fading as melanocytes regenerate
- Cosmetic concern; signals underlying receptor dysfunction